Thomas Theriault
Founder at Bullet Biotechnology, Inc.
Thomas Theriault active positions
Companies | Position | Start | End |
---|---|---|---|
Bullet Biotechnology, Inc.
Bullet Biotechnology, Inc. BiotechnologyHealth Technology Bullet Biotechnology, Inc. develops active immunotherapies to stimulate a person’s own immune system to overcome diseases. Its technology educates the immune system to targeting specific cells that are causing disease. The firm's pipeline includes therapeutic vaccines for cancer, multi-specific antibody capsid products, therapeutic vaccines for autoimmune diseases, and other vaccines. The company was founded by Diego Fonstad, James R. Swartz, Willie Quinn and Thomas Theriault in September 2011 and is headquartered in Redwood City, CA. | Chief Tech/Sci/R&D Officer | 2011-08-31 | - |
Founder | 2011-08-31 | - |
Career history of Thomas Theriault
Former positions of Thomas Theriault
Companies | Position | Start | End |
---|---|---|---|
GENITOPE CORPORATION | Chief Tech/Sci/R&D Officer | 2005-01-31 | 2008-03-30 |
INCYTE CORPORATION | Chief Tech/Sci/R&D Officer | 1996-07-31 | 2004-03-31 |
Combion, Inc.
Combion, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Incyte Corp., Combion, Inc. is a company that develops ink-jet technology for a variety of high-density gridding synthesis applications. The company is based in Pasadena, CA. The company was founded by Thomas Theriault, John D. Baldeschwieler. Combion was acquired by Incyte Corp. on August 15, 1996 for $2.98 million. | Chief Tech/Sci/R&D Officer | 1995-12-31 | 1995-12-31 |
Founder | 1995-12-31 | 1995-12-31 |
Training of Thomas Theriault
Dartmouth College | Undergraduate Degree |
Stanford University | Doctorate Degree |
Statistics
International
United States | 7 |
Operational
Chief Tech/Sci/R&D Officer | 4 |
Founder | 2 |
Undergraduate Degree | 1 |
Sectoral
Health Technology | 4 |
Consumer Services | 3 |
Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
INCYTE CORPORATION | Health Technology |
Private companies | 3 |
---|---|
Genitope Corp.
Genitope Corp. BiotechnologyHealth Technology Genitope Corp. operates as a biotechnology company, which focuses on the research and development of novel immunotherapies for the treatment of cancer. The company was founded on August 15, 1996 and is headquartered in Redwood, CA. | Health Technology |
Combion, Inc.
Combion, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Incyte Corp., Combion, Inc. is a company that develops ink-jet technology for a variety of high-density gridding synthesis applications. The company is based in Pasadena, CA. The company was founded by Thomas Theriault, John D. Baldeschwieler. Combion was acquired by Incyte Corp. on August 15, 1996 for $2.98 million. | Commercial Services |
Bullet Biotechnology, Inc.
Bullet Biotechnology, Inc. BiotechnologyHealth Technology Bullet Biotechnology, Inc. develops active immunotherapies to stimulate a person’s own immune system to overcome diseases. Its technology educates the immune system to targeting specific cells that are causing disease. The firm's pipeline includes therapeutic vaccines for cancer, multi-specific antibody capsid products, therapeutic vaccines for autoimmune diseases, and other vaccines. The company was founded by Diego Fonstad, James R. Swartz, Willie Quinn and Thomas Theriault in September 2011 and is headquartered in Redwood City, CA. | Health Technology |
- Stock Market
- Insiders
- Thomas Theriault
- Experience